Stock Events

Stock Events

Fennec Pharmaceuticals (ADH) Q4 2024 Earnings

7NovConfirmed

Q4 2024

-0.22

-0.17

-0.13

-0.09

Details

Expected EPS

-0.09096006

Actual EPS

-0.21519288

Surprise EPS

-0.12

Surprise Percent

+136.58%

Description

Fennec Pharmaceuticals (ADH) has reported earnings of -0.21519288 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.